Inappropriate prescriptions sending hospitalized seniors back to the ER

August 05, 2020

Two in three hospitalized seniors are prescribed drugs that should be avoided by older adults, increasing the risk of injury and adverse drug reactions. Improving hospital prescribing practices can reduce the frequency of inappropriate medications and resulting harm, according to a new study led by McGill University researchers.

Potentially inappropriate medications (PIMs) are drugs that should be avoided by seniors because the risk of harm or injury outweighs the expected benefit, particularly when safer or more effective alternatives are available for the same condition. A new study published in Journal of the American Geriatrics Society is the first to examine the impact of these medications as a result of decisions made by care teams during hospital stays.

As patients recover, they are especially vulnerable in the short-term period after discharge, when the associated risks and adverse reactions can result in emergency department visits, rehospitalization, and even death within 30 days.

Navigating the risks and benefits of medications

To estimate the number of PIMs prescribed to patients, the researchers analyzed data from hospital admissions records, provincial health databases, and filled prescriptions in Quebec between October 2014 and November 2016.

The results they found were surprising. "The risks associated with some of these drugs are well-known to clinicians, yet they are still commonly prescribed," says lead author Daniala Weir, a former doctoral trainee under the supervision of Robyn Tamblyn in the Department of Epidemiology and Biostatistics. "Benzodiazepines, for example, are typically used to treat anxiety and insomnia in adults, but are known to increase the risk of falls for seniors."

Clinicians may judge that the benefit of a PIM outweighs the harm for their patient. "This could be true in specific situations; however, on the whole, these medications still tend to cause more harm than good for the average older adult," says Weir.

The researchers conclude that these findings demonstrate a need not only for further research into the risks associated with continuing PIMs at hospital discharge, but also for better guidance to improve prescribing practices in hospitals for older adults.

" Dr.Weir has identified important and preventable risk factors for avoidable harm in hospitalized seniors. With the introduction of computerized discharge prescriptions, there can be an automated review and alerts for potentially inappropriate medications; interventions that have proven to be effective in reducing PIMs in other jurisdictions," says Professor Tamblyn.
About the study

"Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events" by Daniala L. Weir, Todd C. Lee, Emily G. McDonald, Aude Motulsky, Michal Abrahamowicz, and Steven Morgan, David Buckeridge, and Robyn Tamblyn is published in the Journal of the American Geriatrics Society.


About McGill University

Founded in Montreal, Quebec, in 1821, McGill University is Canada's top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It?is a world-renowned institution of higher learning with research activities spanning two campuses, 11 faculties, 13 professional schools, 300 programs of study and over 40,000 students, including more than 10,200 graduate students. McGill attracts students from over 150 countries around the world, its 12,800 international students making up 31% of the student body. Over half of McGill students claim a first language other than English, including approximately 19% of our students who say French is their mother tongue.

McGill University

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to